Protocol

Moxidectin in Onchocerciasis: Ongoing Clinical Trial Protocols 3

Moxidectin in Onchocerciasis: Ongoing Clinical Trial Protocols: MDGH-MOX-1006: A pharmacokinetic and safety study of moxidectin to identify an optimal dose for treatment of children 4 to 11 years (Target: at least 27 participants).

Moxidectin in Onchocerciasis: Ongoing Clinical Trial Protocols: MDGH-MOX-1006: A pharmacokinetic and safety study of moxidectin to identify an optimal dose for treatment of children 4 to 11 years (Target: at least 27 participants).